logo

For the Inventor, By the Inventor

Amsterdam, Netherlands

Bioalliance C.v.

Calculating rank
USPTO Granted Patents = 10

% Expired Patents = 60.0



Forward Citations = 133

Loading Chart...
Loading Chart...

9 inventors (with patents filed for the assignee):

goldMedal Shih-Yao Lin (10 out of 27 patents)

silverMedal Rong-Hwa Lin (7 out of 20 patents)

bronzeMedal Yu-Ying Tsai (5 out of 7 patents)

4.  Leewen Lin (5 out of 5 patents)

5.  Chiu-Chen Huang (4 out of 12 patents)

6.  Yu-Chi Hsieh (4 out of 5 patents)

7.  Shu-Hua Lee (3 out of 4 patents)

8.  Feng-Lin Chiang (1 out of 2 patents)

9.  Li-An Hu (1 out of 1 patent)


10 patents:

1. 10472422 - Tetravalent anti-PSGL-1 antibodies and uses thereof (2019-11-12),
2. 9950077 - Anti-folate receptor alpha (FRA) antibody-drug conjugates and methods of using thereof (2018-04-24),
3. 9943610 - Hydrophilic self-immolative linkers and conjugates thereof (2018-04-17),
4. 9408923 - Hydrophilic self-immolative linkers and conjugates thereof (2016-08-09),
5. 9334329 - Antibodies recognizing a carbohydrate containing epitope on CD-43 and CEA expressed on cancer cells and methods using same (2016-05-10),
6. 9193794 - Antibodies recognizing a carbohydrate containing epitope on CD-43 and CEA expressed on cancer cells and methods using same (2015-11-24),
7. 9089614 - Hydrophilic self-immolative linkers and conjugates thereof (2015-07-28),
8. 8568718 - Antibodies recognizing a carbohydrate containing epitope on CD-43 and CEA expressed on cancer cells and methods using same (2013-10-29),
9. 7982017 - Antibodies recognizing a carbohydrate containing epitope on CD-43 and CEA expressed on cancer cells and methods using same (2011-07-19),
10. 7674605 - Antibodies recognizing a carbohydrate containing epitope on CD-43 and CEA expressed on cancer cells and methods using same (2010-03-09),
Company Overview
Bioalliance C.v. is a biotechnology company based in Amsterdam, specializing in the development of innovative solutions for healthcare and life sciences. The organization focuses on harnessing advanced biotechnological methods to create products that address unmet medical needs, particularly in the fields of drug delivery and therapeutic applications. With a commitment to research and development, Bioalliance aims to contribute significantly to the advancement of medical technologies and improve patient outcomes globally.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

10 Patents

#61 in Amsterdam

#619 in Netherlands

#56,100 in the World

Amsterdam, NL
Amsterdam, Netherlands

Bioalliance C.v.

Forward Citations = 133

9 inventors:

goldMedal Shih-Yao Lin (10 out of 27 patents)

silverMedal Rong-Hwa Lin (7 out of 20 patents)

bronzeMedal Yu-Ying Tsai (5 out of 7 patents)

4.  Leewen Lin (5 out of 5 patents)

5.  Chiu-Chen Huang (4 out of 12 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Bioalliance C.v.. Retrieved from https://idiyas.com/company/bioalliance-c-v

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…